Direct anti-cancer effect of oncostatin M on chondrosarcoma-Reference-Cited by-同舟云学术

Direct anti-cancer effect of oncostatin M on chondrosarcoma

Published:2011-01-06 Issue:8 Volume:128 Page:1822-1835
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

David Emmanuelle,Guihard Pierre,Brounais Bénédicte,Riet Anne,Charrier Céline,Battaglia Séverine,Gouin François,Ponsolle Stéphanie,Bot Ronan Le,Richards Carl D.,Heymann Dominique,Rédini Françoise,Blanchard Frédéric

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference49 articles.

1. Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment;Bovee;Lancet Oncol,2005

2. Towards a new understanding and classification of chondrogenic neoplasias of the skeleton-biochemistry and cell biology of chondrosarcoma and its variants;Aigner;Virchows Arch,2002

3. The clinical approach towards chondrosarcoma;Gelderblom;Oncologist,2008

4. Cartilage tumours and bone development: molecular pathology and possible therapeutic targets;Bovee;Nat Rev Cancer,2010

5. COX-2 expression in chondrosarcoma: a role for celecoxib treatment?;Schrage;Eur J Cancer,2010

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exercise Suppresses Head and Neck Squamous Cell Carcinoma Growth via Oncostatin M;Cancers;2024-03-18

2. Interleukin-6 Family of Cytokines in Cancers;Journal of Interferon & Cytokine Research;2024-02-01

3. The clinical relevance of OSM in inflammatory diseases: a comprehensive review;Frontiers in Immunology;2023-09-29

4. Oncostatin M and Nivolumab Affect the Cytotoxic T-Cell Proportions and the Susceptibility to TRAIL-Induced Death in Non-Leukocyte Cell Subpopulations in Soft Tissue Sarcomas;Pharmacology;2023

5. Oncostatin M: Risks and Benefits of a Novel Therapeutic Target for Atherosclerosis;Current Drug Targets;2022-10